2022
Illusory responses across the Alzheimer’s disease spectrum and Lewy body disease spectrum
Shahid M, Rawls A, Ramirez V, Ryman S, Santini V, Yang L, Sha S, Hall J, Montine T, Lin A, Henderson V, Cholerton B, Yutsis M, Poston K. Illusory responses across the Alzheimer’s disease spectrum and Lewy body disease spectrum. Alzheimer's & Dementia 2022, 18 DOI: 10.1002/alz.063733.Peer-Reviewed Original ResearchLewy body disease spectrumLewy bodies patientsDisease spectrumDisease Research CenterAlzheimer's disease spectrumCognitive impairmentDisease patientsLBD patientsIllusory responsesAlzheimer's Disease Research CenterMeasurable cognitive impairmentNon-hallucinating patientsAlzheimer's disease patientsImpact of diagnosisMild cognitive impairmentClinical dementiaGroups' demographic characteristicsDiagnosis groupsVisual hallucinationsComprehensive motorParkinson's diseasePatientsOrdinal regression analysisCognitive declineAlzheimer's disease
2020
Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms
Greenberg DR, Sohlberg EM, Zhang CA, Santini VE, Comiter CV, Enemchukwu EA. Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms. Urology 2020, 144: 99-105. PMID: 32681915, DOI: 10.1016/j.urology.2020.06.063.Peer-Reviewed Original ResearchConceptsSacral nerve stimulationOveractive bladder symptomsPD patientsParkinson's disease patientsDisease patientsBladder symptomsNerve stimulationHigh maximal urethral closure pressureMaximal urethral closure pressurePost-void residual volumeStage IILevodopa equivalent daily dosePD disease durationStage I trialVoids/dayStage I patientsUrethral closure pressureEquivalent daily doseMale PD patientsBody mass indexLong-term outcomesSafety of treatmentRate of progressionLatest clinicDisease duration